Effect of Battlefield Acupuncture on Pain Control During Inpatient Treatment of Exertional Rhabdomyolysis

NCT07528300 | Recruiting

• 1 other identifier: TAMC 23H29 / 223057
• Study Type: interventional
• Target: 36
• Locations: 1 country
• Sites: 1

Brief Summary

Patients admitted with exertional rhabdomyolysis will be offered treatment with battlefield acupuncture for pain management and compared with patient's pain levels and pain medication requirements with those patients who declined battlefield acupuncture.

Conditions

Rhabdomyolysis

Keywords

battlefield acupuncture; rhabdomyolysis; pain management

Outcome Measures

Primary Outcomes (2)

• Pain Level on a pain scale of 0-10

  Reported pain levels on a subjective pain score of 0-10

  Pain level will be measured through study completion (up to 12 months).

• Pain Medication

  Amount of pain medication required, Morphine equivalent and acetaminophen use on hospital days 1-7

  From enrollment to the end of treatment at 12 months

Secondary Outcomes (1)

• Length of Hospital Stay in days

  Length of time from admission to discharge in days (up to 7 days)

Study Arms (2)

Battlefield Acupuncture

ACTIVE COMPARATOR

Patients admitted with rhabdomyolysis who choose to get battlefield acupuncture for pain control.

Procedure: Battlefield Acupuncture

Patients admitted with rhabdomyolysis who did not receive battlefield acupuncture

NO INTERVENTION

This arm is the retrospective group that did not receive the BFA as an intervention.

Interventions

Battlefield Acupuncture PROCEDURE

Treatment of pain from rhabdomyolysis with battlefield acupuncture

Battlefield Acupuncture

Eligibility Criteria

• Age: 18 Years - 99 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Rhabdomyolysis
• chooses battlefield acupuncture

You may not qualify if:

• Greater than 72 hours from onset of symptoms
• younger than 18 years of age
• declines battlefield acupuncture
• no pain

Sponsors & Collaborators

• Tripler Army Medical Center: lead

Study Sites (1)

Tripler Army Medical Center

TAMC, Hawaii, 96859, United States

RECRUITING

MeSH Terms

Conditions

Rhabdomyolysis; Agnosia

Condition Hierarchy (Ancestors)

Muscular Diseases; Musculoskeletal Diseases; Perceptual Disorders; Neurobehavioral Manifestations; Neurologic Manifestations; Nervous System Diseases; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Study Officials

• Chelsea W Tagawa, MD

  Tripler Army Medical Center

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Chelsea W Tagawa, MD

CONTACT

808-433-2202; chelsea.w.tagawa.civ@health.mil

Susan A Scrivner, MS

CONTACT

808-433-5486; susan.a.scrivner.ctr@health.mil

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NON RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: FED
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: May 15, 2025
• First Posted: April 14, 2026
• Study Start: April 24, 2023
• Primary Completion (Estimated): April 24, 2028
• Study Completion (Estimated): April 24, 2028
• Last Updated: April 14, 2026

Record last verified: 2026-04

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)